| Literature DB >> 27484500 |
Ahmed Mohsen1,2,3, Charles Saby3, Philippe Collery4, Gilane Mohamed Sabry2, Rasha Elsherif Hassan2, Abdelfattah Badawi5, Pierre Jeannesson3, Didier Desmaële6, Hamid Morjani7.
Abstract
Two water soluble gallium complexes described as [Ga(III)LCl], where L is the deprotonated form of N-2-hydroxybenzyl aspartic acid derivatives, were synthesized and characterized by (1)H NMR, (13)C NMR, FT-IR, mass spectrometry, and elemental analysis. The 2-(5-chloro-2-hydroxybenzylamino)succinic acid derivative (GS2) has been found to be a promising anticancer drug candidate. This compound was found to be more cytotoxic against human breast carcinoma MDA-MB231 and fibrosarcoma HT-1080 cell lines than the unsubstituted derivative and GaCl3. GS2 was able to induce apoptosis through downregulation of AKT phosphorylation, G2M arrest in cell cycle, and caspase 3/7 pathway. This gallium complex was found to induce an increase in mitochondrial ROS level in HT-1080 cells but not in MDA-MB231 cells. This suggests that the mechanism of action of GS2 would not be mediated by the drug-induced oxidative stress but probably by directly and indirectly inhibiting the AKT cell-signaling pathway.Entities:
Keywords: Antitumor activity; Apoptosis; Gallium complex; Reactive oxygen species; Tridendate ligand
Mesh:
Substances:
Year: 2016 PMID: 27484500 DOI: 10.1007/s00775-016-1382-7
Source DB: PubMed Journal: J Biol Inorg Chem ISSN: 0949-8257 Impact factor: 3.358